EuroIntervention | Your reference journal for coronary, valvular and structural interventions

Your reference journal for coronary, valvular and structural interventions

Biomimetic balloon-expandable THV in SAA

Original Research

Feb 2

Biomimetic balloon-expandable THV in SAA

Ole De Backer, Vinayak N. Bapat, et al.

The novel DurAVR transcatheter heart valve demonstrated high technical success, favorable 30-day clinical and hemodynamic outcomes, and a low rate of complications in patients with small aortic annuli.

open access

Editorial

Feb 3

TAVI in small aortic roots

Francesco Maisano

The content discusses the evolution and future of transcatheter aortic valve implantation (TAVI) in the management of aortic stenosis, highlighting the need for further innovation to address unmet needs and enable better lifetime management of patients.

free

new issue

Feb 2

A new issue of EuroIntervention

An expert review on 3D intracardiac echocardiography; biomimetic balloon-expandable THV in small aortic annuli; intra-annular TAVI in small aortic annuli; 5-year outcomes of transapical transcatheter mitral valve replacement; impact of coronary dominance on left main PCI prognosis; 5-year outcomes of the COMPARE trial; distal foot artery access compression; the retrieval of a stuck TAVI device; and more...

letter to the editor

Jan 30

Letter: Beta blocker withdrawal post-MI

Ahmed B. Shamsulddin

The REBOOT trial confirmed the ischemic safety of withdrawing beta-blockers after successful myocardial infarction treatment, but did not address the impact on patient symptoms and quality of life.

free

letter to the editor

Jan 30

Reply: Beta blocker withdrawal post-MI

Xavier Rossello, Borja Ibanez

The study found that abrupt beta blocker withdrawal in post-MI patients with preserved LVEF is not associated with increased ischemic risk or impaired quality of life.

free

Original Research

Jan 28

Medium-term outcomes in transcatheter PVL closure

Grégoire Albenque, Sebastien Hascoet, et al.

This prospective, multicentre study evaluated medium-term outcomes and predictors of mortality or surgical reintervention after transcatheter paravalvular leak closure in 213 high-risk patients.

Medium-term outcomes in transcatheter PVL closure

Editorial

Jan 27

Residual MPG after TAVI

Tobias Rheude, Héctor Alfonso Alvarez Covarrubias

The ESC/EACTS guidelines recommend TAVI as the preferred treatment for aortic valve stenosis in patients aged ≥70 years, and highlight the importance of multimodal imaging and hemodynamic assessment in predicting structural valve deterioration.

free

Turning Point Podcast

Listen now

State-of-the-Art

Jan 29

State-of-the-Art collection 2024-2025

EuroIntervention is pleased to share our collection of State-of-the-Art articles from 2024-2025. Join us in looking back on the past two years of high-level insights on key topics of interventional interest, written by top-tier international experts.

Original Research

Jan 26

Structural valve deterioration and mortality after TAVI

Tullio Palmerini, Nazzareno Galiè, et al.

This study found that early residual mean postprocedural gradient after TAVI is an independent predictor of structural valve deterioration, which is associated with high rates of bioprosthetic valve failure and increased 10-year mortality.

Structural valve deterioration and mortality after TAVI

State of the Art

Jan 23

Lesion stratification with IC imaging

Michael McGarvey, Nilesh Pareek, et al.

This article explores how intracoronary imaging can transform the assessment and management of coronary artery disease by enabling detailed lesion characterization, guiding interventional strategies, identifying high-risk plaques, and informing targeted therapies.

free

Editorial

Jan 22

Meta-analyses of M-TEER trials

Christian Besler, Dirk Westermann

The study discusses the increasing use of mitral transcatheter edge-to-edge repair (M-TEER) procedures in Europe and the need for further improvements in patient outcomes through refined approaches targeting specific patient subgroups.

free

Meta-analysis

Jan 21

M-TEER vs GDMT

Nicola Ammirabile, Davide Capodanno, et al.

This meta-analysis of 3 randomized trials found that in patients with symptomatic moderate-to-severe functional mitral regurgitation, TEER plus GDMT reduced the composite endpoint of death or heart failure hospitalization and heart failure hospitalization at 24 months compared to GDMT alone.

Research Correspondence

Jan 20

AF following PFO closure using ICM

Paul Gautier, Meyer Elbaz, et al.

This study found a high incidence of asymptomatic and paroxysmal atrial fibrillation following patent foramen ovale closure, with a significant proportion of late-onset episodes beyond 30 days.

open access

Flashlight

Jan 19

Paraplegia after TAVI

Ralf Zahn, Ralph Winkler, et al.

A 78-year-old male with severe aortic stenosis underwent TAVI, but the valve spontaneously twisted and migrated, leading to a hypoxic-ischemic injury. The authors propose recommendations for managing this complication.